Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus ramipril for endothelial dysfunction in essential hypertension
2009-016738-28Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in essential hypertension comparing Aliskiren with Ramipril (2 arms). Primary endpoints: Percent modification of forearm blood flow induced by endothelial agonists and antagonists, Percent inhibition by L-NMMA on endothelium-dependent vasodilation and 3 more. Started Nov 2009; status: completed.
02
Drugs
aliskirenramipril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2009-016738-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016738-28.